Ledger.Open graph →
SEC Form D · filed July 13, 2017

Innocrin Pharmaceuticals Holdings, LLC

Offering
$13.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Archie C. Black · Minneapolis, MNDirectorCharles A. Wilkinson · New York, NYDirectorMarcus Katz · Chicago, ILDirectorMichael A. Smerklo · Minneapolis, MNDirectorRobin Rose · Boston, MAExec · DirectorJames J. Frome · Minneapolis, MNDirectorJames B. Ramsey · Minneapolis, MNDirectorKimberly K. Nelson · Minneapolis, MNDirectorConstantinos J. Christofilis · Seattle, WADirectorArchon Capital Management LLC · Seattle, WADirectorStephen A. Mcshea · New York, NYDirectorDonald M. Wilkinson Iii · New York, NYExec · DirectorCharles E. Osborne · Durham, NCExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗